We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Reagent Red Cell Products Unveiled at Annual Blood Banking Meeting

By LabMedica International staff writers
Posted on 03 Nov 2014
Four new reagent red cell diagnostic products were unveiled at a blood banking meeting.

The annual meeting of the American Association of Blood Banks (AABB) that was held in Philadelphia, PA, USA from October 25–28, 2014, was selected for the launch of new red cell reagent diagnostic products produced by Quotient Limited (St Helier, Jersey).

The four new products are: (1) ALBAcyte Expanded Rh Negative Antibody Screen, (2) ALBAcyte Antibody Identification Panel (16-cell), (3) ALBAcyte Antibody Screen (two-cell), and (4) ALBAzyme Papain Solution Kit.

The ALBAcyte Expanded Rh Negative Antibody Screen will be of particular use with pregnant, Rh-negative women who have been treated with Rh immunoglobulin. More...
Its Rh-negative cells detect all the unexpected antibodies required of traditional screens. The ALBAcyte Antibody Identification Panel (16-cell) is a full antibody identification panel with six complementary cells. The ALBAcyte Antibody Screen (two-cell) is a robust antibody screen for those laboratories that prefer a two-cell screen, or frequently test pediatric or other small-volume samples. Red cells incorporated in this product have been carefully selected to maximize homozygosity, thus optimizing the detection of antibodies. The ALBAzyme Papain Solution Kit is a kit combining both papain and enzyme control, which pairs with the existing papain-treated ALBAcyte Antibody Identification Panel (10-cell), to better allow laboratories to treat and test auto-controls and patient samples.

"These four new products expand our reagent red cell offering, including the addition of a number of novel products," said Jeremy Stackawitz, president of Quotient Limited. "Quotient's product offering can now address all the needs of the vast majority of blood bank laboratories, truly making it a one-stop-shop for reagent red cells."

Related Links:
Quotient Limited



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Portable POCT Blood Gas Analyzer
BD100
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.